Cagrilintide is being researched primarily in metabolic models, focusing on its effects on body weight, food intake, and metabolic outcomes
We are supervised by Board-certified doctors and provide a wide range of vaccinations, laboratory services, drug testing, skin testing, diagnostic testing, physical exams, and more
Patient outcome scale: after the treatment period, patients were asked on a five-point scale whether they perceived an effect of the treatment
Limbutara, K., Chou, C
The further synergistic combination approach with other gastrointestinal hormones and creation of dual GIP/GLP-1 receptor agonists, such as tirzepatide and GLP-1/GIP/glucagon receptor triagonist, retatrutide, has shown unprecedented pharmacologically achieved weight loss with further cardiometabolic benefits in both obesity and T2DM
View our before and after gallery and patient testimonials to explore real patient results